Skip to content

UCB Pharma

UCB is a global biopharmaceutical company focused on creating solutions for people living with neurological and autoimmune conditions.

Last updated September 15, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

UCB describes itself as a global biopharmaceutical leader focused on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions. It states that it is powered by more than 9,000 people, operating from its headquarters in Belgium and across nearly 40 countries worldwide, and that its people have lived its purpose each day since 1928. Its research and development activity spans neurology, immunology, and other areas where its expertise aligns. UCB also offers UCBCares®, a personalized helpline service supporting people living with a disease and healthcare professionals during their treatment journey with a UCB medicine, and operates the UCB Community Health Fund, launched in 2020 to address health disparities among vulnerable populations.

History

UCB states that its people have lived its purpose each day since 1928, making critical investments in biopharmaceutical research and leading innovations. The UCB Community Health Fund was launched in 2020 to address health disparities among vulnerable populations, taking into consideration their physical and mental health, and social well-being. In 2026, the Fund began a new chapter with a refreshed approach, partnering with fewer organizations but building deeper, longer-term relationships; for the 2026–2028 cycle it will support twelve organizations across countries where UCB has a strong presence, with each partner receiving €100,000 per year for three years (€300,000 in total).

Products and positioning

A global biopharmaceutical leader focused on neurological and autoimmune conditions.

  • UCBCares®

    A personalized service offered by UCB to support people living with a disease and healthcare professionals during their treatment journey with a UCB medicine.

  • UCB Community Health Fund

    Launched in 2020 to address health disparities among vulnerable populations.

  • UCB Ventures

    Invests in pioneering companies and technologies that have the potential to transform the lives of people living with severe diseases.

Sources4 sources

Cite this profile: Cite the canonical profile. /brand-wiki/ucb-pharma · Editorial policy · How profiles are compiled